Evidence map›Paper›PMID 39337892›Full record

ReviewLife (Basel, Switzerland)2024

Advantages of Robotic Surgery for Patients of Reproductive Age with Endometrial Cancer.

Magdalena Bizoń, Zuzanna Roszkowska, Renata Kalisz, Łukasz Szarpak, Maciej Olszewski

Abstract readReview
In one paragraph

Review in Life (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Magdalena BizońLUX MED Oncology Hospital, św. Wincentego 103, 03-291 Warsaw, Poland.ORCID 0000-0001-9513-106X
Zuzanna RoszkowskaStudents' Scientific Club "ROBOTICS", Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0009-0008-8923-9689
Renata KaliszStudents' Scientific Club "ROBOTICS", Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0009-0000-4509-9647
Łukasz SzarpakDepartment of Clinical Research and Development, LUXMED Group, 02-676 Warsaw, Poland.ORCID 0000-0002-0973-5455
Maciej OlszewskiLUX MED Oncology Hospital, św. Wincentego 103, 03-291 Warsaw, Poland.ORCID 0000-0003-2295-633X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review presents current knowledge on the surgical treatment of endometrial cancer in young patients. Endometrial cancer is the most common gynecological cancer in Europe. Higher morbidity is correlated with obesity, hypertension and diabetes, which are growing worldwide. However, endometrial cancer at an early age is very rare. The first line of treatment for this cancer is radical hysterectomy, which is controversial in young women. There is an alternative method of fertility-sparing treatment. However, there is a group of young patients for whom surgical treatment is recommended. According to European guidelines, minimally invasive surgery is recommended for endometrial cancer. The aim of the study was to present the advantages of robotic surgery for endometrial cancer detected at a young age. The procedure of radical treatment with robot-assisted laparoscopy is more precise. Better visualization and stabilization of instruments allow a shorter procedure time, a brief hospital stay and fewer complications. Quality of life may be at a similar level. Incisions after trocars are painless and more esthetic than a classical wound. Bilateral adnexectomy in endometrial cancer depends on age, molecular status of the cancer, stage, genetic risk factors and individual decision. Conclusions: Robotic surgery seems to be a better surgical method for endometrial cancer in younger patients.

Indexed as

BRCA mutationendometrial cancerminimally invasive surgeryrobot-assisted laparoscopyyoung age

Identifiers

PMID39337892
PMCPMC11432957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.